Microbiome regulates the capacity for immune surveillance of soft tissue sarcoma and response to oncolytic virus immunotherapy.

被引：0
|
作者：
Sikdar, Saif U. [1 ]
Kim, Daesun [2 ]
Wang, Tie [3 ]
Zemp, Franz [2 ]
Mahoney, Douglas [3 ]
机构：
[1] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada
[2] Charbonneau Canc Res Inst, Calgary, AB, Canada
[3] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B18
引用
收藏
页码：58 / 58
页数：1
相关论文
共 31 条
  • [1] Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma
    MacNeill, Amy L.
    Weishaar, Kristen M.
    Seguin, Bernard
    Powers, Barbara E.
    [J]. VIRUSES-BASEL, 2018, 10 (08):
  • [2] Immune landscape and response to oncolytic virus-based immunotherapy
    Lin, Chaolong
    Teng, Wenzhong
    Tian, Yang
    Li, Shaopeng
    Xia, Ningshao
    Huang, Chenghao
    [J]. FRONTIERS OF MEDICINE, 2024, 18 (03) : 411 - 429
  • [3] Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
    Gentschev, Ivaylo
    Adelfinger, Marion
    Josupeit, Rafael
    Rudolph, Stephan
    Ehrig, Klaas
    Donat, Ulrike
    Weibel, Stephanie
    Chen, Nanhai G.
    Yu, Yong A.
    Zhang, Qian
    Heisig, Martin
    Thamm, Douglas
    Stritzker, Jochen
    MacNeill, Amy
    Szalay, Aladar A.
    [J]. PLOS ONE, 2012, 7 (05):
  • [4] Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
    Sousa, Luana Madalena
    Almeida, Jani Sofia
    Fortes-Andrade, Tania
    Santos-Rosa, Manuel
    Freitas-Tavares, Paulo
    Casanova, Jose Manuel
    Rodrigues-Santos, Paulo
    [J]. CANCERS, 2021, 13 (15)
  • [5] The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
    Woo, Yanghee
    Warner, Susanne G.
    Geha, Rula
    Stanford, Marianne M.
    Decarolis, Penelope
    Rahman, Masmudur M.
    Singer, Samuel
    McFadden, Grant
    Fong, Yuman
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [6] Exploration of tertiary lymphatic structure in soft tissue sarcoma for the prognostic and immunotherapy response
    Xiang-Xu, W.
    Jing-Yi, R.
    Xiao-Wen, W.
    Hong-Mei, Z.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1039 - S1040
  • [7] Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer
    Umer, Brittany A.
    Noyce, Ryan S.
    Franczak, Brian C.
    Shenouda, Mira M.
    Kelly, Rees G.
    Favis, Nicole A.
    Desaulniers, Megan
    Baldwin, Troy A.
    Hitt, Mary M.
    Evans, David H.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (05) : 618 - 631
  • [8] Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models
    Hatta, Masahiko
    Kaibori, Masaki
    Matsushima, Hideyuki
    Yoshida, Terufumi
    Okumura, Tadayoshi
    Hayashi, Mikio
    Yoshii, Kengo
    Todo, Tomoki
    Sekimoto, Mitsugu
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2022, 25 : 225 - 235
  • [9] Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma
    Wu, Changwu
    Duan, Yingjuan
    Gong, Siming
    Osterhoff, Georg
    Kallendrusch, Sonja
    Schopow, Nikolas
    [J]. CANCERS, 2022, 14 (02)
  • [10] Impact of viral sensitizer-enhanced oncolytic virus immunotherapy on the anti-tumor immune response
    Alluqmani, Nouf N.
    Bergeron, Anabel
    Chen, Andrew
    Khan, Sarwat
    Forbes, Nicole
    Arulanandam, Rozanne
    Souza, Christiano
    Crans, Debbi C.
    Diallo, Jean-Simon
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
1234